Precision Medicine Conference San Diego 2027

Genomics and data vendors

Why a precision medicine conference in San Diego suits genomics and data companies

ImmunoMark is a precision medicine conference in San Diego for the point where sequence data becomes an oncology decision: which patients enroll, which biomarker drives the label, which combination goes forward. On 10–11 February 2027 it runs in the city that grew into the center of the sequencing industry, with both streams in play for genomics, CGP, data and AI vendors.

Most precision medicine meetings spread across every therapy area. ImmunoMark is oncology only, and it pairs a Next-Gen Immuno-Oncology stream with a Biomarkers & Companion Diagnostics stream. For a genomics or data company, that is useful: immuno-oncology programs generate the hardest multi-omic and patient-selection problems, and the biomarker stream is where those problems become diagnostic and commercial decisions.

The speaker faculty shows who is buying. It includes Suhas Vasaikar, Director, Translational Oncology Bioinformatics at Pfizer; Dinesh Kumar, Head of Translational Research Bioinformatics at Roche; Javier Perez, Senior Director, Precision Medicine Strategy, Translational Medicine at Regeneron; and Christina Waters, CEO of Archer Precision Medicine.

2parallel streams, both relevant to genomics and data

300+senior delegates expected at the launch edition

45–50%senior leadership in the audience profile

200+meetings conducted at London 2026

Two-stream itinerary

A precision oncology conference in San Diego, across both streams

Genomics and data buyers do not sit in one stream. This is a real-agenda plan for splitting your team across both, with the reason each session matters to a sequencing, CGP, AI or RWE vendor.

When	Session	Why your team should be there
Day 1, 09:00 · Stream 1	Keynote: Shaping the Future of Precision Immuno-Oncology Through Artificial Intelligence and Next-Generation Therapeutics	Sets the AI and data agenda for IO program leads
Day 1, 10:00 · Stream 2	Decoding Response and Resistance to Immunotherapy in NSCLC Through Integrative Multi-Omic and AI Approaches (Ariel (Yung-Chia) Chen, Johnson & Johnson)	Multi-omic data integration in a live pharma program
Day 1, 14:00 · Stream 2	Advancing Next-Generation Precision Diagnostics Through Genomics and Molecular Technologies (Merlinda-Loriane Sewavi, Syntheia Labs)	The core NGS and molecular diagnostics conversation
Day 1, 15:00 · Stream 1	Personalized Cancer Vaccines and Neoantigen Discovery for Next-Generation Immunotherapies	Neoantigen pipelines depend on sequencing and bioinformatics
Day 1, 17:00 · Stream 1	Computational Immunology and Digital Twin Technologies for Precision Cancer Treatment	Modeling and data platform buyers
Day 2, 16:00 · Stream 2	Real-World Evidence and Digital Biomarkers Supporting Clinical Decision Making	RWE and health-data use cases
Day 2, 16:30 · Stream 1	Artificial Intelligence for Optimizing Clinical Trial Design and Patient Selection	Patient selection is where genomic data earns its budget

A team of three covers this comfortably: one person per stream plus one floating between booth and 1:1 meetings. If your offer is closer to a regulated diagnostic than to data, the companion diagnostics page fits better. If you serve cell therapy and IO programs directly, see the cancer immunotherapy page for San Diego.

Who signs off

Translational medicine conference San Diego buyers, by function

Data and genomics spend in oncology is rarely owned by one department. These are the three functions you need on your meeting list.

Translational bioinformatics

Own multi-omic pipelines and data integration
Evaluate data quality, formats and analysis tooling
Often the technical gatekeeper for a platform decision

Precision medicine strategy

Decide which biomarkers and tests a program relies on
Evaluate CGP coverage, turnaround and global access
Connect biomarker choices to companion diagnostic plans

Clinical development and trial design

Use genomic data and AI for patient selection
Evaluate real-world evidence for trial planning
Control the largest budgets once a program moves to the clinic

The program was built for this mix. As a precision medicine conference in California with an oncology-only focus, it brings these functions into one two-day room instead of spreading them across a broad therapy-area meeting. If you are comparing precision medicine conference San Diego 2027 options with the wider series, the precision medicine series page compares San Diego, London and Boston.

Model the return from meetings with bioinformatics and precision medicine leads.

Run the ROI calculator

Package fit

Which packages fit NGS, data and AI vendors

Your buyers span both streams, but your talk only needs to land in one. Pick the stream where your strongest customer story sits, and use passes and meetings to cover the other.

Best fit

Gold

Enough passes to staff both streams, a talk on Day 2, and meetings to follow up with bioinformatics and precision medicine leads.

30-minute talk on Day 2, pre-lunch, in your chosen stream
6 pre-scheduled 1:1 meetings
6 delegate + 6 client passes
10 x 6 ft booth
Half-page brochure advertisement

Headline

The only package whose keynote slot runs across both streams, for a genomics leader that wants to own the precision oncology conversation at the launch edition.

Welcome speech plus a 30-minute Day 1 keynote across both streams
15 pre-scheduled 1:1 meetings
20 x 12 ft exhibition space
10 delegate + 10 client passes
“Powered by” branding and email to the full pre-qualified database

Drinks reception branding

One evening that every delegate from both streams shares. A focused way to be seen by both sides of the room.

Exclusive branding of the Day 1 drinks reception
5-minute welcome speech
2 passes
Add an Exclusive 1:1 Meetings package for pre-scheduled meetings

Every tier includes the delegate list with contact details and post-event branding. Full package details are on the San Diego sponsorship opportunities page. For a sponsor planning a precision oncology summit in 2027 across more than one city, the same packages are available in London and Boston.

Tell us which stream your strongest story belongs in, and we will suggest the right slot.

Request the prospectus

Proof from London 2026

What the meeting model delivered last time

The San Diego launch edition uses the format proven at London 2026: 300+ delegates from 100+ companies, 70% senior decision-makers, 200+ meetings conducted, and 15–25 meetings per sponsor. Companies that took part included GSK, Roche, Merck, AstraZeneca, Johnson & Johnson and Bristol Myers Squibb.

Ask for the San Diego prospectus and current availability.

Request the prospectus

Sponsorship ROI calculator

What could San Diego 2027 be worth to your team?

Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.

1. Choose a package

Sponsorship packages

Exclusive 1:1 meeting packages

2. Your numbers

Average first-year deal value

Year-one value of a new pharma or biotech customer

Extra conversations at the event

Booth visits, networking and questions after your talk

Become a real opportunity

Share of conversations worth a proposal

Opportunities you usually win

Your typical close rate

Your total event budget

Sponsorship plus travel and team costs

Estimated return

expected first-year revenue for every $1 of your event budget

Pre-scheduled 1:1 meetings

Qualified conversations

New opportunities

Cost per conversation

Pipeline created

Expected revenue won

Get pricing and the prospectus for this package Or talk to our team about a custom package

Estimates only, based on the numbers you enter. Meetings and inclusions from the San Diego 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.

What sponsors said

Feedback from London 2026 sponsors

Here is what sponsors told us at our London 2026 launch edition.

We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

Project Manager

PromoCell GmbH · Sponsor, London 2026

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

BD Manager Europe

Secretech · Sponsor, London 2026

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

Research Account Manager

Miltenyi Biotec · Sponsor, London 2026

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

Senior Business Development Director Europe

Rouken Bio · Sponsor, London 2026

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

Epigenomics Applications Specialist

Hologic Diagenode · Sponsor, London 2026

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Biopharma Business Development Manager EMEA

Hologic Diagenode · Sponsor, London 2026

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

Business Development Executive

HistologiX · Sponsor, London 2026

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Product Specialist

HAWK Biosystems · Sponsor, London 2026

Get the prospectus

Frequently asked questions

We sell sequencing, genomic data or analytics, not a therapy or an assay. Who will we meet?

Translational bioinformatics, precision medicine strategy and clinical development teams at biotech and pharma companies, who make up 55–60% of the audience profile. The San Diego speaker faculty includes translational bioinformatics leaders from Pfizer and Roche and precision medicine strategy from Regeneron.

Should we sponsor Stream 1 or Stream 2?

Choose the stream where your strongest customer story sits. Stream 2 suits NGS, CGP and RWE vendors (genomics and molecular diagnostics, real-world evidence sessions). Stream 1 suits AI and computational vendors (AI keynote, neoantigen discovery, computational immunology, AI for trial design and patient selection). Headline is the only package with a keynote across both streams.

How many people should we bring to cover both streams?

Three is a practical minimum: one per stream and one for the booth and 1:1 meetings. Gold includes 6 delegate passes plus 6 client passes, Platinum 8 + 8 and Headline 10 + 10.

Is there AI and real-world evidence content, or only wet-lab biomarkers?

Both. The San Diego agenda includes Real-World Evidence and Digital Biomarkers Supporting Clinical Decision Making, Artificial Intelligence for Optimizing Clinical Trial Design and Patient Selection, and Decoding Response and Resistance to Immunotherapy in NSCLC Through Integrative Multi-Omic and AI Approaches.

Can we combine San Diego with other ImmunoMark editions?

Yes. Packages are the same at every edition. London runs on 3–4 March 2027 and Boston in June 2027, so you can use San Diego for the US launch and add Europe or the East Coast.

Precision Medicine Conference San Diego: Sequencing Meets Oncology

Get the prospectus and package availability